|
|||||||
Similar Items
- Grossman's Cardiac Catheterization, Angiography, and Intervention by Donald S. Baim
- 150 Practice ECGs by George J. Taylor
- Invasive Hemodynamics in the Catheterization Laboratory: Self-Assessment and Review by Michael Eisenhauer
- Challenging ECGs by Henry J. L. Marriott
- Atlas of Interventional Cardiology by Verghese Mathew
- Just the Facts: ECG Interpretation by Lippincott
- Quick and Accurate 12-Lead ECG Interpretation by Dale Davis
- CT of the Heart: Principles and Applications by U. Joseph Schoepf
| Customer Reviews |
| Be the first to review this product |
Browse Titles In Related Subjects
Additional Description
List of contributors.
Preface.
Section one: Epidemiology .
1 Epidemiology of non-ST-segment elevation acute coronary syndromes.
David Hasdai and Alexander Battler .
Section two: Pathophysiology .
2 Pathologic findings in acute coronary syndromes .
Erling Falk .
3 Vascular biology of acute coronary syndromes .
Lina Badimon .
Section three: Clinical aspects of ACS .
4 Clinical aspects of acute coronary syndromes .
Eugene McFadden .
5 Circulating biomarkers for risk stratif ication .
Christopher Heeschen .
Section four: Investigation in ACS .
6 Coronary angiography, angioscopy, and intravascular ultrasound in non-ST segment elevation acute coronary syndromes .
Eric Van Belle, Christophe Bauters, Fran çois Schiele, and Michel E. Bertrand .
7 New coronary imaging in acute coronary syndrome .
Pim J. de Feyter, Evelyne Regar, and Nico R.A. Mollet .
Section five: Special groups of patients .
8 Acute coronary syndromes in special groups of patients .
Piero O. Bonetti, Michael J. Zellweger, Christoph Kaiser, and Matthias E. Pfisterer .
Section six: Pharmacological treatment .
9 Antiischemic treatment (nitrates, β -blockers, calcium antagonists) .
David McCarty, Colum G. Owens, and A.A. Jennifer Adgey .
10 Antiplatelet therapies: aspirin, thienopyridines, and glycoprotein IIb/IIIa receptor inhibitors .
Jaydeep Sarma and Keith A.A. Fox .
11 Antithrombin drugs: LMWH, unfractionated heparin, direct thrombin inhibitors .
Raphaelle Dumaine and Gilles Montalescot .
12 Statin therapy in ACS .
Fran çois Schiele .
Section seven: Myocardial revascularization .
13 Percutaneouscoronary interventionsand stenting/CABG in non-ST-segment elevation acute coronary syndromes .
Nicolas Meneveau and Jean-Pierre Bassand .
Section eight: Therapeutic strategy .
14 Risk stratification and therapeutic strategy .
Christian W. Hamm .
15 Indication for revascularization in non-ST-elevation acute coronary syndrome .
Lars Wallentin .
16 Management of patientswith nonamenable lesions for myocard ial revascularization .
Victor Legrand .
17 Non-ST-segment elevation coronary syndromes: European Society of Cardiology guidelines .
Michel E. Bertrand .
18 Non-ST-segment elevation acute coronary syndromes: ACC/AHA guidelines .
Pierre Th éroux .
19 From guidelines to registries .
Luigi Tavazzi .
Section nine: Secondary prevention .
20 Secondary prevention after acute episode of patients presenting with nonpersistent ST-segment elevation .
Michel E. Bertrand .
21 How to detect vulnerable plaque .
Dirk Boese and Raimund Erbel .
22 Local versus systemic prevention treatment .
Mario Togni and Bernhard Meier.
Conclusions.
Index
